Trials / Sponsors / AriBio Co., Ltd.
AriBio Co., Ltd.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in P Alzheimer Disease | Phase 3 | 2022-12-23 |
| Completed | Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease Mild to Moderate Alzheimer's Disease | Phase 2 | 2019-04-01 |